Haleon, the US-based subsidiary of the global consumer health company based in the UK, is initiating a recall of nationwide-distributed Robitussin cough syrup.
The initiation of this recall is instigated by the identification of microbial contamination, presenting a potential hazard of severe infections, with a heightened concern for individuals possessing an elevated susceptibility to such complications.
This determination has been explicitly conveyed by Haleon in an official notice disseminated by the Food and Drug Administration.
As articulated by Haleon, the utilization of the products subject to recall carries the risk of instigating severe or life-threatening fungal infections, particularly affecting individuals with compromised immune systems.
The company underscores that while the majority of users are not anticipated to encounter substantial health issues, it is essential to acknowledge the plausible occurrence of infections necessitating medical intervention, and such an eventuality cannot be entirely dismissed.
Recall Robitussin Products: Lot Numbers and Exp. Date
The recall, a proactive measure undertaken by the pertinent regulatory authorities, encapsulates a range of specific Robitussin products, each identified by their corresponding lot numbers and expiration dates.
This comprehensive identification is crucial for consumers and healthcare professionals alike, providing precise information to ensure accurate identification and removal of the affected products from circulation.
- Robitussin Honey CF Max Day Adult 4oz — October 31, 2025 — T10810
- Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
- Robitussin Honey CF Max Day Adult 8oz — September 30, 2025 — T10808
- Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
Robitussin, a well-established and widely utilized medication, is frequently employed to ameliorate symptoms attributed to various respiratory ailments, including but not limited to colds, flu, hay fever, and other respiratory allergies.
In the context of recent developments, it has become imperative to address a recall associated with this pharmaceutical product.
Haleon advises consumers who have purchased the recalled products to refrain from using them.
For inquiries, customers can contact the company at (800) 245-1040 during Monday through Friday, 8 am to 6 pm Eastern time, or reach out via email at [email protected].